These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8568797)

  • 1. Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-tetraazamacrocycles that inhibit human immunodeficiency virus replication. 2. Effect of heteroaromatic linkers on the activity of bicyclams.
    Bridger GJ; Skerlj RT; Padmanabhan S; Martellucci SA; Henson GW; Abrams MJ; Joao HC; Witvrouw M; De Vreese K; Pauwels R; De Clercq E
    J Med Chem; 1996 Jan; 39(1):109-19. PubMed ID: 8568797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and structure relationships of new N,N',N",N"'-tetrakis (omega-amino alkyl) tetraazamacrocycles.
    Trabaud C; Dessolin J; Camplo M; Hantz O; Zoulim F; Borel C; Meyer M; Pepe G; Chermann JC; Kraus JL
    Antivir Chem Chemother; 1998 Jan; 9(1):73-84. PubMed ID: 9875379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-tetraazamacrocycles that inhibit HIV replication. Effects of macrocyclic ring size and substituents on the aromatic linker.
    Bridger GJ; Skerlj RT; Thornton D; Padmanabhan S; Martellucci SA; Henson GW; Abrams MJ; Yamamoto N; De Vreese K; Pauwels R
    J Med Chem; 1995 Jan; 38(2):366-78. PubMed ID: 7830280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-azamacrocycles that inhibit HIV-1 and HIV-2 replication by antagonism of the chemokine receptor CXCR4.
    Bridger GJ; Skerlj RT; Padmanabhan S; Martellucci SA; Henson GW; Struyf S; Witvrouw M; Schols D; De Clercq E
    J Med Chem; 1999 Sep; 42(19):3971-81. PubMed ID: 10508445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-activity relationships of azamacrocyclic C-X-C chemokine receptor 4 antagonists: analogues containing a single azamacrocyclic ring are potent inhibitors of T-cell tropic (X4) HIV-1 replication.
    Bridger GJ; Skerlj RT; Hernandez-Abad PE; Bogucki DE; Wang Z; Zhou Y; Nan S; Boehringer EM; Wilson T; Crawford J; Metz M; Hatse S; Princen K; De Clercq E; Schols D
    J Med Chem; 2010 Feb; 53(3):1250-60. PubMed ID: 20043638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First synthesis and evaluation of the inhibitory effects of aza analogues of TSAO on HIV-1 replication.
    Nguyen Van Nhien A; Tomassi C; Len C; Marco-Contelles JL; Balzarini J; Pannecouque C; De Clercq E; Postel D
    J Med Chem; 2005 Jun; 48(13):4276-84. PubMed ID: 15974581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyanion inhibitors of HIV and other viruses. 7. Polyanionic compounds and polyzwitterionic compounds derived from cyclodextrins as inhibitors of HIV transmission.
    Leydet A; Moullet C; Roque JP; Witvrouw M; Pannecouque C; Andrei G; Snoeck R; Neyts J; Schols D; De Clercq E
    J Med Chem; 1998 Dec; 41(25):4927-32. PubMed ID: 9836609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.
    De Clercq E; Yamamoto N; Pauwels R; Baba M; Schols D; Nakashima H; Balzarini J; Debyser Z; Murrer BA; Schwartz D
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5286-90. PubMed ID: 1608936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure--antiadenoviral activity of nitrogen containing macroheterocycles and their analogues.
    Dyachenko NS; Nosach LN; Povnitsa OY; Kuz'min VE; Artemenko AG; Lozitskaya RN; Basok SS; Alexeeva IV; Zhovnovataya VL; Vanden Eynde JJ
    Mikrobiol Z; 2006; 68(5):69-80. PubMed ID: 17388122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and anti-HIV activity of 4'-substituted 4'-thiothymidines: a new entry based on nucleophilic substitution of the 4'-acetoxy group.
    Haraguchi K; Shimada H; Tanaka H; Hamasaki T; Baba M; Gullen EA; Dutschman GE; Cheng YC
    J Med Chem; 2008 Mar; 51(6):1885-93. PubMed ID: 18311897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative structural activity relationship study of bis-tetraazacyclic compounds. A novel series of HIV-1 and HIV-2 inhibitors.
    Joao HC; De Vreese K; Pauwels R; De Clercq E; Henson GW; Bridger GJ
    J Med Chem; 1995 Sep; 38(19):3865-73. PubMed ID: 7562918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication.
    King PJ; Ma G; Miao W; Jia Q; McDougall BR; Reinecke MG; Cornell C; Kuan J; Kim TR; Robinson WE
    J Med Chem; 1999 Feb; 42(3):497-509. PubMed ID: 9986720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An approach towards the synthesis of potential metal-chelating TSAO-T derivatives as bidentate inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
    Chamorro C; Camarasa MJ; Pérez-Pérez MJ; de Clercq E; Balzarini J; San Félix A
    Antivir Chem Chemother; 1998 Sep; 9(5):413-22. PubMed ID: 9875394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-antiviral activity relationship in the series of pyrimidine and purine N-[2-(2-phosphonomethoxy)ethyl] nucleotide analogues. 1. Derivatives substituted at the carbon atoms of the base.
    Holý A; Günter J; Dvoráková H; Masojídková M; Andrei G; Snoeck R; Balzarini J; De Clercq E
    J Med Chem; 1999 Jun; 42(12):2064-86. PubMed ID: 10377214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, activity and toxicity of novel macrocyclic ligands against HIV-1 in Jurkat and CEM-SS cell lines.
    Balogh-Nair V; Brathwaite CE; Chen CX; Vargas J
    Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S9-14. PubMed ID: 8574152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bicyclams, selective antagonists of the human chemokine receptor CXCR4, potently inhibit feline immunodeficiency virus replication.
    Egberink HF; De Clercq E; Van Vliet AL; Balzarini J; Bridger GJ; Henson G; Horzinek MC; Schols D
    J Virol; 1999 Aug; 73(8):6346-52. PubMed ID: 10400726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abasic analogues of TSAO-T as the first sugar derivatives that specifically inhibit HIV-1 reverse transcriptase.
    Velázquez S; Chamorro C; Pérez-Pérez MJ; Alvarez R; Jimeno ML; Martín-Domenech A; Pérez C; Gago F; De Clercq E; Balzarini J; San-Félix A; Camarasa MJ
    J Med Chem; 1998 Nov; 41(23):4636-47. PubMed ID: 9804703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100.
    De Clercq E; Yamamoto N; Pauwels R; Balzarini J; Witvrouw M; De Vreese K; Debyser Z; Rosenwirth B; Peichl P; Datema R
    Antimicrob Agents Chemother; 1994 Apr; 38(4):668-74. PubMed ID: 7913308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and antiviral evaluations of 1-(substituted benzyl)-2-substituted-5,6-dichlorobenzimidazoles as nonnucleoside analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole.
    Porcari AR; Devivar RV; Kucera LS; Drach JC; Townsend LB
    J Med Chem; 1998 Apr; 41(8):1252-62. PubMed ID: 9548815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A new oxa-analog of myristic acid, suppressing replication of the human immunodeficiency virus].
    Vodovozova EL; Mikhalev II; Rzhaninova AA; Garaev MM; Molotkovskiĭ IuG
    Bioorg Khim; 1995 Sep; 21(9):724-30. PubMed ID: 8588818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.